| Mar 5, 2026 |
Mar 6, 2026 |
Cullivan Julie A
|
Director |
Sell |
11.3
|
-9,122
|
-25.05%
|
✓
|
$228.1K |
| Feb 17, 2026 |
Feb 19, 2026 |
BARABE TIMOTHY C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2026 |
Feb 17, 2026 |
Rogers Campbell
|
Chief Medical Officer |
Sell |
13.8
|
-65,153
|
-22.72%
|
✓
|
$1.6M |
| Feb 6, 2026 |
Feb 10, 2026 |
Jones Marie L.
|
Chief Accounting Officer, VP |
Sell |
90.0
|
+21,535
|
212.90%
|
✗
|
$2.6K |
| Feb 6, 2026 |
Feb 10, 2026 |
Farquhar John C.M.
|
CEO |
Sell |
97.5
|
+159,747
|
36.99%
|
✓
|
$662.3K |
| Feb 6, 2026 |
Feb 10, 2026 |
Rogers Campbell
|
Chief Medical Officer |
Sell |
91.3
|
+53,558
|
32.23%
|
✗
|
$14.3K |
| Feb 6, 2026 |
Feb 10, 2026 |
Verghese Vikram
|
CFO |
Sell |
91.3
|
+67,951
|
46.89%
|
✗
|
$15K |
| Feb 5, 2026 |
Feb 6, 2026 |
Cullivan Julie A
|
Director |
Sell |
21.3
|
-8,000
|
-18.01%
|
✓
|
$218.6K |
| Feb 4, 2026 |
Feb 6, 2026 |
Bain Capital Life Sciences Investors, LLC
|
10% Owner |
Sell |
15.0
|
-2,000,000
|
-16.07%
|
✗
|
$56.1M |
| Dec 16, 2025 |
Dec 17, 2025 |
Lightcap Jeffrey C
|
Director |
Buy |
77.5
|
+40,000
|
0.60%
|
✗
|
$1.1M |
| Nov 7, 2025 |
Nov 12, 2025 |
Rogers Campbell
|
Chief Medical Officer |
Sell |
51.3
|
-439
|
-0.26%
|
✗
|
$14.3K |
| Nov 7, 2025 |
Nov 12, 2025 |
Farquhar John C.M.
|
CEO |
Sell |
51.3
|
-1,339
|
-0.31%
|
✗
|
$43.6K |
| Nov 7, 2025 |
Nov 12, 2025 |
Verghese Vikram
|
CFO |
Sell |
51.3
|
-471
|
-0.32%
|
✗
|
$15.3K |
| Nov 7, 2025 |
Nov 12, 2025 |
Jones Marie L.
|
Chief Accounting Officer, VP |
Sell |
50.0
|
-81
|
-0.79%
|
✗
|
$2.6K |
| Aug 11, 2025 |
Aug 22, 2025 |
HealthCor Partners Management LP
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 22, 2025 |
HealthCor Partners Management LP
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2025 |
Aug 13, 2025 |
Bain Capital Life Sciences Investors, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 7, 2025 |
Aug 11, 2025 |
Cullivan Julie A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2025 |
Aug 11, 2025 |
WELDON WILLIAM C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 7, 2025 |
Aug 11, 2025 |
Riley Wayne Joseph
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 7, 2025 |
Aug 11, 2025 |
Farquhar John C.M.
|
CEO |
Neutral |
90.0
|
+59,868
|
16.03%
|
✗
|
- |
| Aug 7, 2025 |
Aug 11, 2025 |
Verghese Vikram
|
CFO |
Neutral |
90.0
|
+21,052
|
18.34%
|
✗
|
- |
| Aug 7, 2025 |
Aug 11, 2025 |
Rogers Campbell
|
Chief Medical Officer |
Neutral |
90.0
|
+21,052
|
14.46%
|
✗
|
- |
| Aug 7, 2025 |
Aug 11, 2025 |
Jones Marie L.
|
Chief Accounting Officer, VP |
Neutral |
90.0
|
+3,618
|
100.00%
|
✗
|
- |
| Aug 11, 2025 |
Aug 11, 2025 |
BARABE TIMOTHY C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2025 |
Aug 11, 2025 |
Tansey Casey M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2025 |
Aug 11, 2025 |
Lightcap Jeffrey C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Bain Capital Life Sciences Investors, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Downing Nicholas
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Verghese Vikram
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Cullivan Julie A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Lightcap Jeffrey C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Jones Marie L.
|
Chief Accounting Officer, VP |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Rogers Campbell
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Farquhar John C.M.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
WELDON WILLIAM C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Tansey Casey M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
Riley Wayne Joseph
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2025 |
BARABE TIMOTHY C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |